{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:59:39Z","timestamp":1740099579790,"version":"3.37.3"},"publisher-location":"Cham","reference-count":54,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030352097"},{"type":"electronic","value":"9783030352103"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-35210-3_5","type":"book-chapter","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T06:03:08Z","timestamp":1573711388000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Flexible Data Trimming for Different Machine Learning Methods in Omics-Based Personalized Oncology"],"prefix":"10.1007","author":[{"given":"Victor","family":"Tkachev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-3424","authenticated-orcid":false,"given":"Anton","family":"Buzdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-5524","authenticated-orcid":false,"given":"Nicolas","family":"Borisov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.07.010","author":"A Buzdin","year":"2019","unstructured":"Buzdin, A., et al.: RNA sequencing for research and diagnostics in clinical oncology. Semin. Cancer Biol. (2019). \nhttps:\/\/doi.org\/10.1016\/j.semcancer.2019.07.010","journal-title":"Semin. Cancer Biol."},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1134\/S000629790805012X","volume":"73","author":"NV Zhukov","year":"2008","unstructured":"Zhukov, N.V., Tjulandin, S.A.: Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochem. Biokhim. 73, 605\u2013618 (2008)","journal-title":"Biochem. Biokhim."},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fonc.2019.00658","volume":"9","author":"N Borisov","year":"2019","unstructured":"Borisov, N., Buzdin, A.: New paradigm of machine learning (ML) in personalized oncology: data trimming for squeezing more biomarkers from clinical datasets. Front. Oncol. 9, 658 (2019). \nhttps:\/\/doi.org\/10.3389\/fonc.2019.00658","journal-title":"Front. Oncol."},{"key":"5_CR4","doi-asserted-by":"publisher","unstructured":"Artemov, A., et al.: A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation. Oncotarget 6, 29347\u201329356 (2015). \nhttps:\/\/doi.org\/10.18632\/oncotarget.5119","DOI":"10.18632\/oncotarget.5119"},{"key":"5_CR5","doi-asserted-by":"publisher","unstructured":"Shepelin, D., et al.: Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human. Oncotarget 7, 656\u2013670 (2016). \nhttps:\/\/doi.org\/10.18632\/oncotarget.6394","DOI":"10.18632\/oncotarget.6394"},{"key":"5_CR6","doi-asserted-by":"publisher","unstructured":"Zolotovskaia, M.A., et al.: Pathway based analysis of mutation data is efficient for scoring target cancer drugs. Front. Pharmacol. 10 (2019). \nhttps:\/\/doi.org\/10.3389\/fphar.2019.00001","DOI":"10.3389\/fphar.2019.00001"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.compbiomed.2018.12.017","volume":"107","author":"T Turki","year":"2019","unstructured":"Turki, T., Wang, J.T.L.: Clinical intelligence: new machine learning techniques for predicting clinical drug response. Comput. Biol. Med. 107, 302\u2013322 (2019). \nhttps:\/\/doi.org\/10.1016\/j.compbiomed.2018.12.017","journal-title":"Comput. Biol. Med."},{"key":"5_CR8","doi-asserted-by":"publisher","unstructured":"Turki, T., Wei, Z.: A link prediction approach to cancer drug sensitivity prediction. BMC Syst. Biol. 11 (2017). \nhttps:\/\/doi.org\/10.1186\/s12918-017-0463-8","DOI":"10.1186\/s12918-017-0463-8"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1109\/ACCESS.2017.2696523","volume":"5","author":"T Turki","year":"2017","unstructured":"Turki, T., Wei, Z., Wang, J.T.L.: Transfer learning approaches to improve drug sensitivity prediction in multiple myeloma patients. IEEE Access 5, 7381\u20137393 (2017). \nhttps:\/\/doi.org\/10.1109\/ACCESS.2017.2696523","journal-title":"IEEE Access"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"1840014","DOI":"10.1142\/S0219720018400140","volume":"16","author":"T Turki","year":"2018","unstructured":"Turki, T., Wei, Z., Wang, J.T.L.: A transfer learning approach via procrustes analysis and mean shift for cancer drug sensitivity prediction. J. Bioinform. Comput. Biol. 16, 1840014 (2018). \nhttps:\/\/doi.org\/10.1142\/S0219720018400140","journal-title":"J. Bioinform. Comput. Biol."},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","volume":"109","author":"G Mulligan","year":"2007","unstructured":"Mulligan, G., et al.: Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib. Blood 109, 3177\u20133188 (2007). \nhttps:\/\/doi.org\/10.1182\/blood-2006-09-044974","journal-title":"Blood"},{"key":"5_CR12","doi-asserted-by":"publisher","unstructured":"Borisov, N., Tkachev, V., Muchnik, I., Buzdin, A.: Individual Drug Treatment Prediction in Oncology Based on Machine Learning Using Cell Culture Gene Expression Data (2017). \nhttps:\/\/doi.org\/10.1145\/3155077.3155078","DOI":"10.1145\/3155077.3155078"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/15384101.2017.1417706","volume":"17","author":"N Borisov","year":"2018","unstructured":"Borisov, N., Tkachev, V., Suntsova, M., Kovalchuk, O., Zhavoronkov, A., Muchnik, I., Buzdin, A.: A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency. Cell Cycle 17, 486\u2013491 (2018). \nhttps:\/\/doi.org\/10.1080\/15384101.2017.1417706","journal-title":"Cell Cycle"},{"key":"5_CR14","series-title":"Lecture Notes in Computer Science (Lecture Notes in Artificial Intelligence)","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-319-99492-5_9","volume-title":"Braverman Readings in Machine Learning. Key Ideas from Inception to Current State","author":"N Borisov","year":"2018","unstructured":"Borisov, N., Tkachev, V., Buzdin, A., Muchnik, I.: Prediction of drug efficiency by transferring gene expression data from cell lines to cancer patients. In: Rozonoer, L., Mirkin, B., Muchnik, I. (eds.) Braverman Readings in Machine Learning. Key Ideas from Inception to Current State. LNCS (LNAI), vol. 11100, pp. 201\u2013212. Springer, Cham (2018). \nhttps:\/\/doi.org\/10.1007\/978-3-319-99492-5_9"},{"key":"5_CR15","doi-asserted-by":"publisher","unstructured":"Tkachev, V., et al.: FLOating-window projective separator (FloWPS): a data trimming tool for support vector machines (SVM) to improve robustness of the classifier. Front. Genet. 9 (2019). \nhttps:\/\/doi.org\/10.3389\/fgene.2018.00717","DOI":"10.3389\/fgene.2018.00717"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/00031305.1992.10475879","volume":"46","author":"NS Altman","year":"1992","unstructured":"Altman, N.S.: An introduction to kernel and nearest-neighbor nonparametric regression. Am. Stat. 46, 175\u2013185 (1992). \nhttps:\/\/doi.org\/10.1080\/00031305.1992.10475879","journal-title":"Am. Stat."},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/bioinformatics\/btr300","volume":"27","author":"L Tolo\u015fi","year":"2011","unstructured":"Tolo\u015fi, L., Lengauer, T.: Classification with correlated features: unreliability of feature ranking and solutions. Bioinformatics 27, 1986\u20131994 (2011). \nhttps:\/\/doi.org\/10.1093\/bioinformatics\/btr300","journal-title":"Bioinformatics"},{"key":"5_CR18","unstructured":"Tikhonov, A.N., Arsenin, V.I.: Solutions of Ill-Posed Problems. Winston\u202f; Distributed solely by Halsted Press, Washington (1977)"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"e0207204","DOI":"10.1371\/journal.pone.0207204","volume":"13","author":"H-J Cho","year":"2018","unstructured":"Cho, H.-J., Lee, S., Ji, Y.G., Lee, D.H.: Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma. PLoS ONE 13, e0207204 (2018). \nhttps:\/\/doi.org\/10.1371\/journal.pone.0207204","journal-title":"PLoS ONE"},{"key":"5_CR20","doi-asserted-by":"publisher","unstructured":"Davoudi, A., Ozrazgat-Baslanti, T., Ebadi, A., Bursian, A.C., Bihorac, A., Rashidi, P.: Delirium prediction using machine learning models on predictive electronic health records data. In: 2017 IEEE 17th International Conference on Bioinformatics and Bioengineering (BIBE), pp. 568\u2013573. IEEE, Washington, DC (2017). \nhttps:\/\/doi.org\/10.1109\/BIBE.2017.00014","DOI":"10.1109\/BIBE.2017.00014"},{"key":"5_CR21","doi-asserted-by":"publisher","unstructured":"Turki, T., Wei, Z.: Learning approaches to improve prediction of drug sensitivity in breast cancer patients. In: 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), pp. 3314\u20133320. IEEE, Orlando, FL, USA (2016). \nhttps:\/\/doi.org\/10.1109\/EMBC.2016.7591437","DOI":"10.1109\/EMBC.2016.7591437"},{"issue":"12","key":"5_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2174\/1568026618666180727152557","volume":"18","author":"Li Zhang","year":"2018","unstructured":"Zhang, L., et al.: Applications of machine learning methods in drug toxicity prediction. Curr. Top. Med. Chem. 18 (2018). \nhttps:\/\/doi.org\/10.2174\/1568026618666180727152557","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"20","key":"5_CR23","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/cmdc.201800533","volume":"13","author":"Zhuang Wang","year":"2018","unstructured":"Wang, Z., et al.: In silico prediction of blood-brain barrier permeability of compounds by machine learning and resampling methods. Chem. Med. Chem. 13, 2189\u20132201 (2018). \nhttps:\/\/doi.org\/10.1002\/cmdc.201800533","journal-title":"ChemMedChem"},{"key":"5_CR24","doi-asserted-by":"publisher","unstructured":"Yosipof, A., Guedes, R.C., Garc\u00eda-Sosa, A.T.: Data mining and machine learning models for predicting drug likeness and their disease or organ category. Front. Chem. 6 (2018). \nhttps:\/\/doi.org\/10.3389\/fchem.2018.00162","DOI":"10.3389\/fchem.2018.00162"},{"key":"5_CR25","volume-title":"Perceptrons - Expanded Edition: An Introduction to Computational Geometry","author":"ML Minsky","year":"1987","unstructured":"Minsky, M.L., Papert, S.A.: Perceptrons - Expanded Edition: An Introduction to Computational Geometry. MIT press, Boston (1987)"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/pmic.200400857","volume":"4","author":"J Prados","year":"2004","unstructured":"Prados, J., Kalousis, A., Sanchez, J.-C., Allard, L., Carrette, O., Hilario, M.: Mining mass spectra for diagnosis and biomarker discovery of cerebral accidents. Proteomics 4, 2320\u20132332 (2004). \nhttps:\/\/doi.org\/10.1002\/pmic.200400857","journal-title":"Proteomics"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1586\/epr.09.83","volume":"6","author":"X Robin","year":"2009","unstructured":"Robin, X., Turck, N., Hainard, A., Lisacek, F., Sanchez, J.-C., M\u00fcller, M.: Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev. Proteomics 6, 675\u2013689 (2009). \nhttps:\/\/doi.org\/10.1586\/epr.09.83","journal-title":"Expert Rev. Proteomics"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1094\/PHYTO-03-17-0098-LE","volume":"108","author":"DH Gent","year":"2018","unstructured":"Gent, D.H., Esker, P.D., Kriss, A.B.: Statistical power in plant pathology research. Phytopathology 108, 15\u201322 (2018). \nhttps:\/\/doi.org\/10.1094\/PHYTO-03-17-0098-LE","journal-title":"Phytopathology"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jclinepi.2013.03.002","volume":"66","author":"JPA Ioannidis","year":"2013","unstructured":"Ioannidis, J.P.A., Hozo, I., Djulbegovic, B.: Optimal type I and type II error pairs when the available sample size is fixed. J. Clin. Epidemiol. 66, 903\u2013910.e2 (2013). \nhttps:\/\/doi.org\/10.1016\/j.jclinepi.2013.03.002","journal-title":"J. Clin. Epidemiol."},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev, J., Jakobsen, J.C., Gluud, C.: Trial sequential analysis in systematic reviews with meta-analysis. BMC Med. Res. Methodol. 17, 39 (2017). \nhttps:\/\/doi.org\/10.1186\/s12874-017-0315-7","journal-title":"BMC Med. Res. Methodol."},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5395\/rde.2015.40.3.249","volume":"40","author":"H-Y Kim","year":"2015","unstructured":"Kim, H.-Y.: Statistical notes for clinical researchers: Type I and type II errors in statistical decision. Restorative Dent. Endodontics 40, 249 (2015). \nhttps:\/\/doi.org\/10.5395\/rde.2015.40.3.249","journal-title":"Restorative Dent. Endodontics"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bmsp.12132","volume":"72","author":"J Lu","year":"2019","unstructured":"Lu, J., Qiu, Y., Deng, A.: A note on type S\/M errors in hypothesis testing. Br. J. Math. Stat. Psychol. 72, 1\u201317 (2019). \nhttps:\/\/doi.org\/10.1111\/bmsp.12132","journal-title":"Br. J. Math. Stat. Psychol."},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1541-0420.2007.00782.x","volume":"63","author":"S Liti\u00e8re","year":"2007","unstructured":"Liti\u00e8re, S., Alonso, A., Molenberghs, G.: Type I and Type II error under random-effects misspecification in generalized linear mixed models. Biometrics 63, 1038\u20131044 (2007). \nhttps:\/\/doi.org\/10.1111\/j.1541-0420.2007.00782.x","journal-title":"Biometrics"},{"key":"5_CR34","first-page":"I377","volume":"102","author":"RO Cummins","year":"2000","unstructured":"Cummins, R.O., Hazinski, M.F.: Guidelines based on fear of type II (false-negative) errors: why we dropped the pulse check for lay rescuers. Circulation 102, I377\u2013I379 (2000)","journal-title":"Circulation"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.aquatox.2010.09.020","volume":"101","author":"P Rodriguez","year":"2011","unstructured":"Rodriguez, P., Maestre, Z., Martinez-Madrid, M., Reynoldson, T.B.: Evaluating the type II error rate in a sediment toxicity classification using the reference condition approach. Aquat. Toxicol. 101, 207\u2013213 (2011). \nhttps:\/\/doi.org\/10.1016\/j.aquatox.2010.09.020","journal-title":"Aquat. Toxicol."},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis, C., et al.: A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873\u20131881 (2011). \nhttps:\/\/doi.org\/10.1001\/jama.2011.593","journal-title":"JAMA"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-013-2763-z","volume":"143","author":"M Itoh","year":"2014","unstructured":"Itoh, M., et al.: Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative\/progesterone receptor-positive breast cancers. Breast Cancer Res. Treat. 143, 403\u2013409 (2014). \nhttps:\/\/doi.org\/10.1007\/s10549-013-2763-z","journal-title":"Breast Cancer Res. Treat."},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1158\/1078-0432.CCR-12-1359","volume":"19","author":"CE Horak","year":"2013","unstructured":"Horak, C.E., et al.: Biomarker analysis of neoadjuvant doxorubicin\/cyclophosphamide followed by ixabepilone or Paclitaxel in early-stage breast cancer. Clin. Cancer Res. 19, 1587\u20131595 (2013). \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1359","journal-title":"Clin. Cancer Res."},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10549-009-0651-3","volume":"119","author":"LA Korde","year":"2010","unstructured":"Korde, L.A., et al.: Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Res. Treat. 119, 685\u2013699 (2010). \nhttps:\/\/doi.org\/10.1007\/s10549-009-0651-3","journal-title":"Breast Cancer Res. Treat."},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/bcr2611","volume":"12","author":"WR Miller","year":"2010","unstructured":"Miller, W.R., Larionov, A.: Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole. Breast Cancer Res. 12, R52 (2010). \nhttps:\/\/doi.org\/10.1186\/bcr2611","journal-title":"Breast Cancer Res."},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/tpj.2010.67","volume":"12","author":"WR Miller","year":"2012","unstructured":"Miller, W.R., Larionov, A., Anderson, T.J., Evans, D.B., Dixon, J.M.: Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole. Pharmacogenomics J. 12, 10\u201321 (2012). \nhttps:\/\/doi.org\/10.1038\/tpj.2010.67","journal-title":"Pharmacogenomics J."},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/bcr2468","volume":"12","author":"V Popovici","year":"2010","unstructured":"Popovici, V., et al.: Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Res. 12, R5 (2010). \nhttps:\/\/doi.org\/10.1186\/bcr2468","journal-title":"Breast Cancer Res."},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/jnci\/djq524","volume":"103","author":"T Iwamoto","year":"2011","unstructured":"Iwamoto, T., et al.: Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J. Nat. Cancer Inst. 103, 264\u2013272 (2011). \nhttps:\/\/doi.org\/10.1093\/jnci\/djq524","journal-title":"J. Nat. Cancer Inst."},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1349-7006.2012.02231.x","volume":"103","author":"T Miyake","year":"2012","unstructured":"Miyake, T., et al.: GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci. 103, 913\u2013920 (2012). \nhttps:\/\/doi.org\/10.1111\/j.1349-7006.2012.02231.x","journal-title":"Cancer Sci."},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1073\/pnas.1201105109","volume":"109","author":"JC Liu","year":"2012","unstructured":"Liu, J.C., et al.: Seventeen-gene signature from enriched Her2\/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+: ER\u03b1- breast cancer. Proc. Natl. Acad. Sci. U.S.A. 109, 5832\u20135837 (2012). \nhttps:\/\/doi.org\/10.1073\/pnas.1201105109","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1755-8794-5-51","volume":"5","author":"K Shen","year":"2012","unstructured":"Shen, K., et al.: Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial. BMC Med. Genomics 5, 51 (2012). \nhttps:\/\/doi.org\/10.1186\/1755-8794-5-51","journal-title":"BMC Med. Genomics"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.2014.57.8963","volume":"33","author":"AK Turnbull","year":"2015","unstructured":"Turnbull, A.K., et al.: Accurate prediction and validation of response to endocrine therapy in breast cancer. J. Clin. Oncol. 33, 2270\u20132278 (2015). \nhttps:\/\/doi.org\/10.1200\/JCO.2014.57.8963","journal-title":"J. Clin. Oncol."},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","volume":"22","author":"D Chauhan","year":"2012","unstructured":"Chauhan, D., et al.: A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22, 345\u2013358 (2012). \nhttps:\/\/doi.org\/10.1016\/j.ccr.2012.08.007","journal-title":"Cancer Cell"},{"key":"5_CR49","doi-asserted-by":"publisher","unstructured":"Terragna, C., et al.: The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD). Oncotarget 7, 9666\u20139679 (2016). \nhttps:\/\/doi.org\/10.18632\/oncotarget.5718","DOI":"10.18632\/oncotarget.5718"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/leu.2014.140","volume":"28","author":"SB Amin","year":"2014","unstructured":"Amin, S.B., et al.: Gene expression profile alone is inadequate in predicting complete response in multiple myeloma. Leukemia 28, 2229\u20132234 (2014). \nhttps:\/\/doi.org\/10.1038\/leu.2014.140","journal-title":"Leukemia"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/1078-0432.CCR-06-2609","volume":"13","author":"M Raponi","year":"2007","unstructured":"Raponi, M., et al.: Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Clin. Cancer Res. 13, 2254\u20132260 (2007). \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2609","journal-title":"Clin. Cancer Res."},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"D812","DOI":"10.1093\/nar\/gku1073","volume":"43","author":"M Goldman","year":"2015","unstructured":"Goldman, M., et al.: The UCSC cancer genomics browser: update 2015. Nucleic Acids Res. 43, D812\u2013D817 (2015). \nhttps:\/\/doi.org\/10.1093\/nar\/gku1073","journal-title":"Nucleic Acids Res."},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/cncr.29871","volume":"122","author":"JV Tricoli","year":"2016","unstructured":"Tricoli, J.V., et al.: Biologic and clinical characteristics of adolescent and young adult cancers: acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma: biology of AYA cancers. Cancer 122, 1017\u20131028 (2016). \nhttps:\/\/doi.org\/10.1002\/cncr.29871","journal-title":"Cancer"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2014.47136","volume":"1A","author":"Katarzyna Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P., Wiznerowicz, M.: The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. (Poznan, Poland) 19, A68\u2013A77 (2015). \nhttps:\/\/doi.org\/10.5114\/wo.2014.47136","journal-title":"Wsp\u00f3\u0142czesna Onkologia"}],"container-title":["Lecture Notes in Computer Science","Mathematical and Computational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-35210-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T06:08:36Z","timestamp":1573711716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-35210-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030352097","9783030352103"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-35210-3_5","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"12 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ISMCO","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Symposium on Mathematical and Computational Oncology","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Lake Tahoe, NV","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"USA","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2019","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"14 October 2019","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"15 October 2019","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"1","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"ismco2019","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/ismco.net\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Double-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"EasyChair","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"30","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"7","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"0","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"23% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"1","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}